BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$704M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$115M |
| 2 |
iShares US Financials ETF
IYF
|
+$109M |
| 3 |
Visa
V
|
+$108M |
| 4 |
Charter Communications
CHTR
|
+$73.8M |
| 5 |
Honeywell
HON
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.76% |
| 2 | Healthcare | 6.75% |
| 3 | Financials | 5.74% |
| 4 | Consumer Discretionary | 5.28% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
e.l.f. Beauty
ELF
$5.41B
| $111K | ﹤0.01% |
11,286
-224,093
| -95% | -$3.36M |
|
3002
BJ's Restaurants
BJRI
$1.43B
| $111K | ﹤0.01% |
7,995
+2,251
| +39% | +$72.3K |
|
3003
Ethan Allen Interiors
ETD
$579M
| $111K | ﹤0.01% |
10,829
-1,526
| -12% | -$22.3K |
|
3004
Arrow Financial
AROW
$728M
| $110K | ﹤0.01% |
4,459
+932
| +26% | +$27.3K |
|
|
JCP
3005
DELISTED
J.C. Penney Company, Inc.
JCP
| $110K | ﹤0.01% |
305,185
+190,081
| +165% | +$134K |
|
|
CTT
3006
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $109K | ﹤0.01% |
15,158
+3,186
| +27% | +$30.5K |
|
3007
Axogen
AXGN
$2.61B
| $109K | ﹤0.01% |
10,523
+6,573
| +166% | +$83.7K |
|
|
CLDT
3008
Chatham Lodging
CLDT
$598M
| $109K | ﹤0.01% |
18,357
+2,891
| +19% | +$40.4K |
|
3009
UroGen Pharma
URGN
$2.32B
| $109K | ﹤0.01% |
6,098
+3,605
| +145% | +$97.4K |
|
|
HAYN
3010
DELISTED
Haynes International, Inc.
HAYN
| $108K | ﹤0.01% |
5,264
+2,169
| +70% | +$57K |
|
3011
Canadian Pacific Kansas City
CP
$82.4B
| $108K | ﹤0.01% |
2,470
-820
| -25% | -$40.4K |
|
3012
ARK Innovation ETF
ARKK
$6.41B
| $108K | ﹤0.01% |
+2,464
| New | +$126K |
|
|
FSB
3013
DELISTED
Franklin Financial Network, Inc.
FSB
| $108K | ﹤0.01% |
5,312
+2,328
| +78% | +$74.1K |
|
|
BSTC
3014
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $108K | ﹤0.01% |
1,907
+980
| +106% | +$55.8K |
|
3015
HSBC
HSBC
$356B
| $108K | ﹤0.01% |
3,850
-741
| -16% | -$25.7K |
|
3016
Ares Capital
ARCC
$14.3B
| $108K | ﹤0.01% |
9,999
-6,281
| -39% | -$106K |
|
|
CYOU
3017
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $107K | ﹤0.01% |
10,044
+2,839
| +39% | +$29.9K |
|
3018
CytomX Therapeutics
CTMX
$734M
| $107K | ﹤0.01% |
13,998
+8,671
| +163% | +$60.5K |
|
|
KRA
3019
DELISTED
Kraton Corporation
KRA
| $107K | ﹤0.01% |
13,228
+1,825
| +16% | +$27.2K |
|
3020
Dime Commercial Bancshares
DCOM
$1.81B
| $107K | ﹤0.01% |
5,055
+1,033
| +26% | +$29.2K |
|
|
TBIO
3021
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $107K | ﹤0.01% |
10,722
+6,670
| +165% | +$54.6K |
|
3022
First Mid Bancshares
FMBH
$1.39B
| $107K | ﹤0.01% |
4,500
+952
| +27% | +$28.5K |
|
3023
Digi International
DGII
$3.22B
| $107K | ﹤0.01% |
11,191
+1,507
| +16% | +$20.9K |
|
3024
Hain Celestial
HAIN
$53.4M
| $106K | ﹤0.01% |
4,098
-7,998
| -66% | -$200K |
|
3025
Waterstone Financial
WSBF
$383M
| $106K | ﹤0.01% |
7,313
+1,508
| +26% | +$25.6K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2020 Portfolio in Review
As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.
- BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
- BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
- BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
- BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
- BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.